|
Code CURE |
Name Global X S&P Biotech ETF |
Country AU |
Currency AUD |
|
GIC Sector N/A |
GIC Group N/A |
GIC Industry N/A |
GIC Sub Industry N/A |
|
Yield 0.00% |
Dividend Frequency N/A |
Inception 2018-11-08 |
Total Assets $41,612,849 |
| Region | Equity |
|---|---|
| North America | 96.913% |
| United Kingdom | 1.17613% |
| Europe Developed | 1.91% |
| Europe Emerging | 0% |
| Africa/Middle East | 0% |
| Japan | 0% |
| Australasia | 0% |
| Asia Developed | 0% |
| Asia Emerging | 0% |
| Latin America | 0% |
| Region | Equity |
|---|---|
| Basic Materials | 0% |
| Consumer Cyclicals | 0% |
| Financial Services | 0.29021% |
| Real Estate | 0% |
| Communication Services | 0% |
| Energy | 0% |
| Industrials | 0% |
| Technology | 0% |
| Consumer Defensive | 0% |
| Healthcare | 99.70979% |
| Utilities | 0% |
| Region | Code | Country | % |
|---|---|---|---|
| APGE.US | APGE | United States | 1.48% |
| MRNA.US | MRNA | United States | 1.40% |
| PRAX.US | PRAX | United States | 1.35% |
| TWST.US | TWST | United States | 1.34% |
| ORKA.US | ORKA | United States | 1.33% |
| VKTX.US | VKTX | United States | 1.32% |
| KYMR.US | KYMR | United States | 1.29% |
| ERAS.US | ERAS | United States | 1.26% |
| SLS.US | SLS | United States | 1.24% |
| CGON.US | CGON | United States | 1.24% |